Tetanus
240
7
11
201
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Published Results
103 trials with published results (43%)
Research Maturity
201 completed trials (84% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
1.7%
4 terminated out of 240 trials
98.0%
+11.5% vs benchmark
65%
156 trials in Phase 3/4
51%
103 of 201 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 201 completed trials
Clinical Trials (240)
A Phase 4 Study to Evaluate the Effectiveness and Safety of Siltartoxatug Injection for Tetanus Prophylaxis Following Injury
A Study of Tetanus Antibody of Healthy Adults
A Phase Ⅲ Clinical Study of SNA02-48 Injection
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SNA02-48 Injection in Chinese Adult Participants
A First in Human Study Investigating the Safety of an Unloaded and Loaded (With a Tetanus-containing Vaccine Booster) Microneedle Patch in Healthy Adults
Maternal Immunization With Tetanus Toxoid, Reduced Diphtheria Toxoid, Reduced-dose (2 µg) Recombinant Pertussis Vaccine (TdaP2gen) and Its Effect on the Immune Response in Thai Infants up to 15-18 Months Old
Phase I Clinical Trial of Adsorbed Tetanus Vaccine
A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents)
Safety Monitoring of Boostagen® Vaccine in Thailand
TETANUS Antibody Detection in Saliva Study
Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Anti-Tetanus Toxin Monoclonal Antibody Injection
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
A Registry： Siltartoxatug Injection for Tetanus Prophylaxis Following Injury
Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents
Confirmatory Study of BK1310 in Healthy Infants
PFAS Exposure and Immune Response to Vaccination in Adults
Study to Compare the Anti-tetanus Neutralizing Antibody Titers and Safety of TNM002 Injection With Human Tetanus Immunoglobulin or Placebo in Adult Volunteers
A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed
A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series